News
Dubbed Clover Therapeutics, the unit's first project will be a partnership with Genentech targeting ocular diseases among senior populations.
The startup launched three new test kits, which will test for conditions such as chlamydia, gonorrhea and syphilis.
Also: Propeller Health CCO warns against unchecked disruption; Grant brings smartphone diabetic retinopathy screening to India.
The company exclusively announced to MobiHealthNews its plans to create a tool kit for providers, payers and pharmas.
The tech giant's collaboration with the NHS was first announced last year.
Amgen Ventures, Celegene, Echo Health Ventures, Alexandria Venture Investments and Gary Loveman also participated.
Quipcare and the premium Quipcare+ will allow members to schedule professional dental services with upfront costs 30% to 40% less than average, the company said.
From streamlining operations to fine-tuning optimal treatments, the technology makes a business case for pharma.
Entrepreneurs have until 5 August to submit their applications for the RYSE Digital Health Call.